Abstract Views :159 |
PDF Views:0
Authors
Affiliations
1 Zone 48, India Habitat Centre, Lodi Road, New Delhi - 110003, IN
Source
Journal of Indian School of Political Economy, Vol 14, No 4 (2002), Pagination: 647-666
Abstract
In the present paper, an attempt is made to empirically verify the impact of economic liberalisation on the R&D hehaviour of Indian pharmaceutical firms, controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of firms over the period 1989-90 to 2000-01 indicate that competitive pressure generated by liberalisation has worked effectively in pushing Indian pharmaceutical firms into R&D activity. A host of firm characteristics like age, size, profitability, intangible assets, export orientation and outward foreign direct investment of the firm are also found to be important determinants of innovative activity in the industry. The study suggest several policy measures to further indigenous technological efforts of pharmaceutical firms, which include removing obstacles that inhibit outward orientation of firms, providing special scheme for small size firms in the overall technology policy for the industry, intensifying collaborative research efforts between private sectors and government research institution, and utilising flexibilities in the TRIMs agreements to persuade foreign firms to relocate their R&D units into the country.
